Sun Pharma partners with ICGEB to develop dengue vaccine

05:33 EDT 19 Oct 2016 | Pharmafile

Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) to develop a vaccine to tackle dengue and all four of its serotypes.

As part of the partnership, Sun Pharma will have exclusive global rights for the development and commercialisation of the vaccine candidate, and will provide support and funding to further the progress of ICGEB research and patents which include “a tailored recombinant virus-like particle (VLP) based tetravalent dengue vaccine”.

read more

Original Article: Sun Pharma partners with ICGEB to develop dengue vaccine


More From BioPortfolio on "Sun Pharma partners with ICGEB to develop dengue vaccine"

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...